Abstract
Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 167-172 |
| Number of pages | 6 |
| Journal | Journal of oncology practice |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2019 |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Oncology(nursing)
- Health Policy
Cite this
Times not to forget radiotherapy when treating patients with lymphoma. / Enke, Charles A.
In: Journal of oncology practice, Vol. 15, No. 4, 01.04.2019, p. 167-172.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Times not to forget radiotherapy when treating patients with lymphoma
AU - Enke, Charles A.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.
AB - Radiation therapy remains an important component of lymphoma treatment. It has evolved with improvements in technology and a better understanding of how to successfully integrate it into lymphoma treatment. There are specific clinical presentations where omission of radiation therapy could adversely affect patient outcome and should not be overlooked. Radiation therapy may serve an important role as primary treatment, as a component of combined modality therapy, as adjuvant therapy to maximize local control, and as an important component of salvage therapy for relapsed or primary refractory lymphoma and in the successful palliation of lymphoma. This review identifies those clinical presentations where the use of radiation therapy should not be overlooked or should at least be considered.
UR - http://www.scopus.com/inward/record.url?scp=85064721580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064721580&partnerID=8YFLogxK
U2 - 10.1200/JOP.18.00519
DO - 10.1200/JOP.18.00519
M3 - Review article
C2 - 30970228
AN - SCOPUS:85064721580
VL - 15
SP - 167
EP - 172
JO - Journal of Oncology Practice
JF - Journal of Oncology Practice
SN - 1554-7477
IS - 4
ER -